As Bachem is the world’s leading company in developing and manufacturing peptides and oligonucleotides, we receive a lot of interest about our company news and activities.
Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.
All Bachem news
- All
- Ad-hoc
- CMC development
- Commercial APIs
- Finance
- Innovation
- Knowledge
- News
- Oligonucleotides
- Peptides
- Press
- Research & specialties
- Services & capabilities
- Sustainability
- Team
- Trends
01Dec2021
Assessing and Influencing ACE2-Mediated COVID-19 Infection
Corona Virus disease 2019 (COVID-19) affects us all, either directly with an infection or indirectly...
11Nov2021
Bachem lays foundations for company’s largest production building
Bachem lays foundations for the world's most modern production building for peptides and oligonucleo...
19Oct2021
Bachem raises CHF 583.5 million through capital increase
Following the Extraordinary General Meeting, Bachem has successfully raised approximately CHF 584 mi...
18Oct2021
Bachem launches accelerated bookbuilding for approx. 750k new shares
Bachem launches accelerated bookbuilding for approx 750k new shares for capacity expansion and const...
15Oct2021
Extraordinary General Meeting
Authorization of the Board to issue up to 1 million new shares until September 30, 2023...
04Oct2021
How are Peptides Made?
A peptide is a chain of amino acids, which are used as building blocks. More commonly, peptides are ...
Next events coming up
Full event calendar
Interested in joining at one of our upcoming exhibitions, conferences or webinars? View our full calendar of events.